Clinical Trials List
Protocol NumberCEPO906A2213
Not yet recruiting
2005-10-01 - 2007-06-01
Phase II
Terminated2
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- PEI-JER CHEN Digestive System Department
- Chih-Hung Hsu Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
- 夏和雄 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
70 participants
